Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

Clinical trial NCT01109264 · COMPLETED

Trial details

NCT number: NCT01109264
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2010-03-01
Primary completion: 2013-06-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.